Treatment modalities in COVID 19

Öz

1. Organization WH. Coronavirus (COVID-19). 2020. 2020.
2. Mishra E, Goyal AK, Rath G. Recent advances in drug delivery systems in antiviral therapy. 2018.
3. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71.
4. Oldfield V, Plosker GL. Lopinavir/ritonavir. Drugs. 2006;66(9):1275-99.
5. Llibre JM. Development of darunavir over the entire spectrum of HIV infection. Enfermedades Infecciosas y Microbiologia Clinica. 2018;36:3-9.
6. Khalili JS, Zhu H, Mak NSA, Yan Y, Zhu Y. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19. Journal of medical virology. 2020.
7. Cao Y-c, Deng Q-x, Dai S-x. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Medicine and Infectious Disease. 2020:101647.
8. Deng L, Li C, Zeng Q, Liu X, Li X, Zhang H, et al. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. Journal of Infection. 2020.